Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Nuvectis Pharma Inc
Swot
Nuvectis Pharma Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Nuvectis Pharma Inc has 23 Strengths, 3 Weaknesses, 1 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(23)
Weakness
(3)
Opportunity
(1)
Threats
(3)
Others
(0)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
High Normalized Momentum Score
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Stock gained more than 20% in one month
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Volume Shockers
High Volume, High Gain
Biggest Price Gainers from Open
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Institutions increasing their shareholding
Stocks rising sharply on very low month volumes
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter